ampicillin has been researched along with Disease Models, Animal in 158 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 48 (30.38) | 18.7374 |
1990's | 31 (19.62) | 18.2507 |
2000's | 22 (13.92) | 29.6817 |
2010's | 42 (26.58) | 24.3611 |
2020's | 15 (9.49) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Chong, CR; Liu, JO; Shi, L; Sullivan, DJ | 1 |
Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Nakamura, S; Seki, M; Yamada, K; Yamamoto, Y; Yanagihara, K | 1 |
Chen, CS; Chen, YR; Chiu, HC; Kapuriya, N; Kulp, SK; Lee, SL; Teng, LJ; Wang, D; Yu, SL | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH | 1 |
Aftab, N; Eijaz, S; Hanif, U; Iqbal, R; Liaqat, I; Naseem, S; Rubab, S | 1 |
Bessonov, K; Chmara, J; Dan, H; Devenish, J; Guan, J; Gurnik, S; Kang, M; Laskey, A; Lin, M; Liu, K; Nash, JHE; Robertson, J; Savic, M; Topp, E | 1 |
Bohlmann, L; Brazel, EB; Cunningham, BA; De Oliveira, DMP; Eijkelkamp, BA; El-Deeb, IM; Ganio, K; Iverson, AR; Keller, B; Maher, MJ; McDevitt, CA; McEwan, AG; Neville, SL; Rosch, JW; Sikanyika, M; Tan, A; Udagedara, SR; von Itzstein, M; Walker, MJ | 1 |
Ariki, S; Chalalai, T; Dewayani, A; Fujitsuka, N; Fukuda, C; Hidano, S; Ishizawa, S; Ito, K; Kamiyama, N; Kobayashi, T; Kubota, K; Kudo, Y; Minata, M; Mizukami, K; Mogami, S; Murakami, K; Nishiyama, M; Ozaka, S; Ozaki, T; Sachi, N; Soga, Y; Sonoda, A | 1 |
Cao, G; Gu, Y; Shao, F; Tian, X; Wang, Z; Wu, X; Yan, T | 1 |
Akhtar, S; Cosgrove, C; Dellacecca, ER; Engelhard, VH; Knight, KL; Le Poole, IC; Mukhatayev, Z; Rademaker, AW | 1 |
McCune, BT; Pfeiffer, JK; Robinson, CM; Woods Acevedo, MA | 1 |
Arnold, SLM; Barrett, LK; Choi, R; Hulverson, MA; McCloskey, MC; Rabago, L; Shaheen, S | 1 |
Althouse, MH; Jiang, W; Lingappan, K; Moorthy, B; Stewart, C | 1 |
Bar-David, E; Ben-Shmuel, A; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
Kulkarni, S; Pasricha, PJ; Saha, M; Sears, CL; Sylvia, KE; Yarandi, SS | 1 |
Arias, CA; Dinh, AQ; Kebriaei, R; Khan, A; Murray, BE; Rice, SA; Rybak, MJ; Singh, KV; Stamper, KC; Tran, TT | 1 |
Alasmari, F; Alhaddad, H; Bell, RL; Sari, Y; Wong, W | 1 |
Jimenez-Toro, I; Otalvaro, JD; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
Balunets, DV; Gintsburg, AL; Luyksaar, SI; Nesterenko, LN; Sheremet, AB; Soloveva, AV; Zayakin, ES; Zigangirova, NA | 1 |
Dong, W; Li, X; Liu, M; Lu, H; Lu, W; Tan, C; Wang, C; Wang, G; Wu, Z | 1 |
Dozier, BL; Grigsby, PL; Houser, LA; Kelleher, MA; Kroenke, CD; Liu, Z; Martin, LD; McEvoy, C; Schelonka, RL; Waites, KB; Wang, X | 1 |
Baker, DL; Chapman, HD; Fahey, JR; Hendrix, NK; Lyons, BL; Mourino, AJ; Olekszak, HL; Racine, JJ; Ratiu, JJ; Serreze, DV | 1 |
Dybowski, R; Grant, AJ; Maskell, DJ; Mastroeni, P; Restif, O; Rossi, O | 1 |
Bhowal, AC; Kalita, S; Kandimalla, R; Kotoky, J; Kundu, S | 1 |
Alshehri, FS; Hakami, AY; Sari, Y | 1 |
Behrendt, U; Berger, S; Dietert, K; Goekeri, C; Gruber, AD; Gupta, SK; Lienau, J; Nouailles, G; Suttorp, N; Vera, J; Wienhold, SM; Witzenrath, M | 1 |
Aysan, E; Demirci, S; Ercan, C; Firat, D; Idiz, UO; Sahin, F | 1 |
Jin, Q; Jing, P; Liang, T; Shen, C; Zhang, N; Zhang, Y | 1 |
Boisen, N; De Tolla, LJ; Melton-Celsa, AR; Nataro, JP; O'Brien, AD; Panda, A; Smith, MA; Tatarov, I; Zangari, T | 1 |
Hansen, AK; Holgersen, K; Holm, TL; Kvist, PH; Markholst, H | 1 |
Chen, Y; Han, JF; Wang, SJ; Wang, YS; Zhang, D; Zhao, SJ | 1 |
Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
Burrin, DG; Cilieborg, MS; Jensen, BB; Jensen, ML; Kelly, D; Lykke, M; Mulder, I; Mølbak, L; Sangild, PT; Schmidt, M; Thymann, T | 1 |
Ghoneim, HE; McCullers, JA | 1 |
Athanazio, DA; de Azevedo, EC; dos Reis, MG; dos Santos, AC; Macedo, JO; Sampaio, Mde Q; Santos, CS; Soares, LM | 1 |
Agudelo, M; Gonzalez, JM; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
Blankenberg, FG; Contag, CH; Hardy, JW; Levashova, Z; Schmidt, TL | 1 |
Chowdhury, N; Kwan, BW; Wood, TK | 1 |
Bonde, Y; Rudling, M | 1 |
Dvornik, IA; Nepomnyashchiy, VV; Shakalova, EA; Tamm, TI | 1 |
Gui, QF; Lu, HF; Xu, ZR; Yang, YH; Zhang, CX | 1 |
Bowlin, AK; Fisher, DJ; Johnson, CM; Lowden, NM; Yeruva, L | 1 |
Birck, MM; Cilieborg, MS; Damborg, P; Kamal, SS; Lauridsen, C; Nguyen, DN; Nielsen, DS; Olsen, JE; Sangild, PT; Thymann, T | 1 |
Levesque, CL; Li, J; Lim, D; St Pierre, B; Turner, J; Wales, P; Wizzard, P | 1 |
Ahmad, A; Christiansen, LE; Græsbøll, K; Matthews, L; Nielsen, SS; Olsen, JE; Toft, N; Zachariasen, C | 2 |
Arakawa, T; Fujiwara, Y; Gi, M; Nagami, Y; Sawada, A; Shiba, M; Tanaka, F; Tanigawa, T; Tominaga, K; Wanibuchi, H; Watanabe, T; Yamagami, H | 1 |
Buytaert, JA; Decraemer, WF; Dirckx, JJ; Von Unge, M | 1 |
Boyd, KL; English, BK; Karlström, A; McCullers, JA | 1 |
Huang, FR; Li, XZ; Luo, ZQ; Tang, YJ; Wang, MJ; Yan, HM; Yue, SJ; Zhou, FW | 1 |
Amagase, K; Kato, S; Ochi, A; Sugihara, T; Takeuchi, K | 1 |
Deng, X; Huang, F; Ji, G; Jian, C; Li, L; Liu, S; Luo, Z; Shang, L; She, H; Wang, M; Yu, X; Yue, S | 1 |
Chen, L; Duan, K; Shen, L; Surette, M; Yang, L | 1 |
Alim, AA; Elgaher, WA; Hayallah, AM; Salem, OI | 1 |
Kaur, S; Kochhar, R; Prasad, KK; Ray, P; Vaishnavi, C | 1 |
Bishop, J; Kellum, JA; Murugan, R; Peng, ZY; Rimmelé, T; Singbartl, K; Srisawat, N; Wang, HZ; Wen, X | 1 |
Andriankaja, O; Bae, HJ; Bezerra, Bde B; Fine, DH; Graves, DT; Kang, J; Li, Y; Pacios, S; Schreiner, H; Tsiagbe, V | 1 |
Alim, AA; Hayallah, AK; Talhouni, AA | 1 |
Hirano, T; Ichimiya, I; Kodama, S; Noda, K; Suzuki, M | 1 |
Alper, CM; Doyle, WJ; Hebda, PA; Piltcher, OB; Swarts, JD; Zeevi, A | 1 |
Evans, SM; Whittle, BJ | 1 |
Gabazza, EC; Hattori, R; Majima, Y; Shimizu, S; Shimizu, T | 1 |
Chaiworapongsa, T; Cutright, J; Espinoza, J; Fidel, P; Ghezzi, F; Gomez, R; Romero, R; Wolf, N | 1 |
Herma, M; Kaufmann, SH; Koch, M; Köhler, A; Kursar, M; Mittrücker, HW | 1 |
McCullers, JA | 1 |
Athanasopoulos, G; Donta, I; Galani, L; Giamarellou, H; Iliopoulos, D; Pefanis, A; Sakka, V | 1 |
Hartiala, K; Hytönen, J; Oksi, J; Söderström, KO; Viljanen, MK; Yrjänäinen, H | 1 |
Arpacik, M; Bagcivan, I; Ceran, C; Karadas, B; Kaya, T; Sarac, B | 1 |
Aladag, I; Eyibilen, A; Guven, M; Köseoglu, D; Sahin, S | 1 |
Adams, KM; Axthelm, MK; Gravett, MG; Grosvenor, AR; Novy, MJ; Sadowsky, DW; Witkin, SS | 1 |
Arda, B; Calik, S; Pullukcu, H; Sipahi, H; Sipahi, OR; Tasbakan, M; Turhan, T; Ulusoy, S; Yamazhan, T | 1 |
Bac, V; Bohnenstengel, S; Gründling, M; Hung, O; Lehmann, Ch; Lindequist, U; Meissner, K; Murphy, M; Pavlovic, D; Saeger, D; Usichenko, T; Wendt, M; Whynot, S | 1 |
Emmerling, P; Hof, H; Seeliger, HP | 1 |
Anderson, JD; Beskid, G; Cleeland, R; Eftekhar, F; Kramer, MJ | 1 |
Mattie, H; van der Voet, GB; van Furth, R | 2 |
Bluestone, CD; Cantekin, EI; Doyle, WJ; Kim, HK; Reilly, JS; Rohn, DD; Supance, JS | 1 |
Loock, CA; McCracken, GH; Schaad, UB; Thomas, ML | 1 |
Lynch, G; McAvinchey, DJ; McCollum, PT | 1 |
Sande, MA; Scheld, WM | 1 |
Orito, M | 1 |
Hedström, KG; Lahnborg, G; Nord, CE | 1 |
Alper, C; Burckart, GJ; Diven, WF; Doyle, WJ; Evans, RW; Jaffe, R | 1 |
Coudron, PE; Lavoie, SR; Markowitz, SM; Williams, DS; Wong, ES | 1 |
Gibbs, RS; Heddleston, L; McDuffie, RS | 1 |
Furuya, N; Hirakata, Y; Matsumoto, T; Tateda, K; Yamaguchi, K | 1 |
Hiroe, K; Iizawa, Y; Kitamoto, N; Nakao, M | 1 |
Blanton, SJ; Charland, SL; Gibbs, RS; McDuffie, RS | 1 |
Gibbs, RS; McDuffie, RS | 1 |
Cross, SE; Roberts, MS; Thompson, MJ | 1 |
Paton, AW; Paton, JC | 1 |
Alder, JD; Ewing, PJ; Mitten, MJ; Strake, JG | 1 |
Fernández-Roblas, R; Gadea, I; García-Corbeira, P; Ponte, C; Soriano, F | 1 |
Miao, XQ; Yin, YH; Yuan, ZH | 1 |
Ryzhko, IV; Samokhodkina, ED; Shcherbaniuk, AI; Tsetskhladze, NS; Tsuraeva, RI | 1 |
Mikelsaar, M; Mikelsaar, RH; Naaber, P; Salminen, S | 1 |
Bhatt, SM; Burkard, RF; Merchant, SN; Nadol, JB; Rappaport, JM | 1 |
Granert, C; Lindquist, L; Raud, J; Waage, A | 1 |
Backo, M; Bayer, AS; Burkart, A; Chai, YL; Gaenger, E | 1 |
Harada, H; Kita, E; Kurioka, T; Yunou, Y | 1 |
Chow, JW; Donabedian, SM; Kak, V; Kariyama, R; Kumon, H; Zervos, MJ | 1 |
Giamarellou, H; Iliopoulos, D; Karayiannakos, P; Katsarolis, I; Pefanis, A; Siaperas, P | 1 |
Beste, DJ; Fox, MC; Kehl, KS; Kerschner, JE; Lynch, JB | 1 |
Kapukaya, A; Kaya, H; Kesemenli, C; Sari, I; Subasi, M | 1 |
Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
McGhee, JR; Michalek, SM | 1 |
Mandaleris, CD; Sande, MA; Strausbaugh, LJ | 1 |
Fukai, K; Kashiwagi, Y; Okubo, N; Shibata, M; Zenyoji, H | 1 |
Braude, AI; Glauser, MP; Lyons, JM | 2 |
Ritzerfeld, W | 1 |
Bergan, T | 1 |
Cleeland, R; Grunberg, E; Kramer, MJ | 1 |
Bartlett, JG; Chang, TW; Gorbach, SL; Gurwith, M; Onderdonk, AB | 1 |
Eckert, P; Eichen, R; Schassan, HH | 1 |
Bodine, JA; Sande, MA; Strausbaugh, LJ | 1 |
Durack, DT; Pelletier, LL; Petersdorf, RG | 1 |
Petzoldt, D | 1 |
Eliopoulos, GM; Moellering, RC; Thauvin-Eliopoulos, C | 1 |
Ishida, Y; Katsuma, E; Nakajima, R; Namba, K; Osada, Y; Otani, T | 1 |
Mattie, H; Sekh, BR; van Furth, R; van Ogtrop, ML; van Strijen, E | 1 |
Hengstler, B; Krinke, G; O'Reilly, T; Sulc, P; Zak, O | 1 |
Kaiser, AB; Kernodle, DS; Parker, RA | 1 |
Kobashi, K; Munakata, K; Satoh, M; Takebe, S; Takeuchi, H; Yoshida, O | 1 |
Blanton, SJ; Gibbs, RS; McDuffie, RS; Shikes, RH | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
Goycoolea, MV; Muchow, DC; Sirvio, LM; Winandy, RM | 1 |
Chenoweth, CE; Robinson, KA; Schaberg, DR | 1 |
Kruglova, IS; Larin, BA; Rastunova, GA; Shcherbakova, EG; Shishlo, VK; Zhuravleva, TP | 1 |
Budinsky, A; Norden, CW | 1 |
Chambers, HF; Kennedy, S; Sachdeva, M | 1 |
Hawkins, EP; Kaplan, SL; Kline, MW; Mason, EO; Patrick, GS | 1 |
Eliopoulos, GM; Hindes, RG; Moellering, RC; Willey, SH | 1 |
Bizzini, B; Fattal-German, M | 1 |
Brook, I | 1 |
Canawati, HN; Ginunas, VJ; Montgomerie, JZ; Sapico, FL | 1 |
Chan, KH; Doyle, WJ; Kardatzke, DR; Swarts, JD; Tanpowpong, K | 1 |
Eliopoulos, GM; Moellering, RC; Thauvin, C; Wennersten, C; Willey, S | 1 |
Gilsdorf, J; Mills, R | 1 |
Hof, H; Kawaler, B | 1 |
Burrous, SE; Eudy, WW; Siedler, AJ | 1 |
Weiser, R | 1 |
Siddons, RC | 1 |
Boyce, W; Bullock, B; Cass, A; Cox, C; Harrison, L | 1 |
Thiele, EH | 1 |
Commichau, R; Freiesleben, H; Henkel, W; Wöhrmann, W | 1 |
Kazmierczak, A; Névot, P; Philippon, A | 1 |
Burrous, SE; Cawein, JB | 1 |
Berezina, EK; Chavdarova, VB; Navashin, SM; Petrova, MA | 1 |
Brázdová, K; Mráz, J; Nezval, J; Sedlácek, J | 1 |
Lisitsa, LI; Rudzit, EA | 1 |
Guze, LB; Hewitt, WL; Kalmanson, GM; Montgomerie, JZ; Sapico, FL | 1 |
Conklin, RH; Mark, HM; Steele, RW | 1 |
Poliak, MS | 1 |
Guze, LB; Hubert, EG; Kalmanson, GM | 1 |
Chamberlain, RE; Das, NK | 1 |
2 review(s) available for ampicillin and Disease Models, Animal
Article | Year |
---|---|
Studies on aminopenicillin developments. Proceedings of a symposium. Concluding remarks.
Topics: Administration, Oral; Amoxicillin; Ampicillin; Animals; Bacteria; Bacterial Infections; Disease Models, Animal; Humans; In Vitro Techniques; Kinetics | 1979 |
[Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Chronic Disease; Corynebacterium; Disease Models, Animal; Dogs; Escherichia coli Infections; Gentamicins; Haplorhini; Kidney; Ligation; Mice; Nalidixic Acid; Nitrofurantoin; Penicillin G; Proteus Infections; Pseudomonas Infections; Pyelonephritis; Rabbits; Rats; Staphylococcal Infections; Streptococcal Infections; Streptomycin; Sulfonamides; Tetracycline; Ureter | 1971 |
156 other study(ies) available for ampicillin and Disease Models, Animal
Article | Year |
---|---|
A clinical drug library screen identifies astemizole as an antimalarial agent.
Topics: Animals; Antimalarials; Astemizole; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance; Drug Resistance, Multiple; Humans; Mice; Plasmodium falciparum; Plasmodium yoelii | 2006 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice.
Topics: Animals; Anti-Bacterial Agents; Bronchioles; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Chemokine CXCL2; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Enzyme-Linked Immunosorbent Assay; Haemophilus Infections; Haemophilus influenzae; Humans; Interleukin-1beta; Male; Mice; Microbial Sensitivity Tests; Neutrophils; Pneumonia; Pulmonary Alveoli | 2010 |
Development of novel antibacterial agents against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; HT29 Cells; Humans; Injections, Intraperitoneal; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2012 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship | 2021 |
Impact of Interplay between Obese Gut Microbiota and Diet in Developing Obesity in Synthetic Community Mice.
Topics: Ampicillin; Animal Feed; Animals; Diet, High-Fat; Disease Models, Animal; Escherichia coli; Gastrointestinal Microbiome; Humans; Klebsiella oxytoca; Lipid Metabolism; Mice; Microbiota; Morganella morganii; Obesity; Pseudomonas aeruginosa; Staphylococcus; Weight Gain | 2021 |
Mobility of
Topics: Ampicillin; Animals; Antibiotic Prophylaxis; beta-Lactam Resistance; beta-Lactamases; Disease Models, Animal; Escherichia coli; Feces; Female; Gene Transfer, Horizontal; Gram-Negative Bacterial Infections; Mice; Proof of Concept Study; RNA, Ribosomal, 16S; Salmonella enterica; Salmonella Infections; Streptomycin; Whole Genome Sequencing | 2021 |
Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model.
Topics: Ampicillin; Ampicillin Resistance; Animals; Anti-Bacterial Agents; Clioquinol; Disease Models, Animal; Female; Homeostasis; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia; Streptococcus pneumoniae; Zinc | 2022 |
Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Colitis; Colitis, Ulcerative; Disease Models, Animal; Drugs, Chinese Herbal; Dysbiosis; Herbal Medicine; Inflammation; Intestinal Mucosa; Japan; Mice; Mice, Inbred C57BL; Vancomycin | 2022 |
Antibiotic ampicillin induces immune tolerance in renal transplantation by regulating the proportion of intestinal flora in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Creatinine; Disease Models, Animal; Gastrointestinal Microbiome; Immune Tolerance; Kidney Transplantation; Mice; Weight Loss | 2022 |
Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice.
Topics: Administration, Oral; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides; Cytokines; Disease Models, Animal; DNA, Bacterial; Dysbiosis; Feces; Female; Humans; Intestinal Mucosa; Male; Mice; Microbiota; Neomycin; Pseudomonas; RNA, Ribosomal, 16S; Skin; T-Lymphocytes, Regulatory; Vitiligo | 2020 |
Related Enteric Viruses Have Different Requirements for Host Microbiota in Mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Coxsackievirus Infections; Disease Models, Animal; Enterovirus; Enterovirus Infections; HeLa Cells; Humans; Male; Mice; Mice, Inbred C57BL; Microbiota; Picornaviridae; Poliovirus; Vancomycin; Virus Replication | 2019 |
Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cell Line; Ciprofloxacin; Disease Models, Animal; Dysentery, Bacillary; Gastrointestinal Tract; Humans; Injections, Intraperitoneal; Luciferases; Luminescent Agents; Luminescent Measurements; Mice; Microbial Sensitivity Tests; Plasmids; Shigella flexneri | 2019 |
Impact of Early Life Antibiotic Exposure and Neonatal Hyperoxia on the Murine Microbiome and Lung Injury.
Topics: Ampicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Disease Models, Animal; Dysbiosis; Female; Gastrointestinal Microbiome; Hyperoxia; Mice; Mice, Inbred C57BL; Pregnancy; Pulmonary Alveoli; RNA, Ribosomal, 16S | 2019 |
Using old antibiotics to treat ancient bacterium-β-lactams for Bacillus anthracis meningitis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Rabbits; Sulbactam | 2020 |
Intestinal Bacteria Maintain Adult Enteric Nervous System and Nitrergic Neurons via Toll-like Receptor 2-induced Neurogenesis in Mice.
Topics: Adult; Ampicillin; Animals; Cells, Cultured; Colon; Disease Models, Animal; Dysbiosis; Enteric Nervous System; Gastrointestinal Microbiome; Gastrointestinal Motility; Germ-Free Life; Humans; Male; Mice; Mice, Transgenic; Myenteric Plexus; Nestin; Neurogenesis; Nitrergic Neurons; Nitric Oxide; Primary Cell Culture; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2020 |
Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Ertapenem; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rats; Sequence Alignment; Transcriptome | 2020 |
Ampicillin/Sulbactam Treatment Modulates NMDA Receptor NR2B Subunit and Attenuates Neuroinflammation and Alcohol Intake in Male High Alcohol Drinking Rats.
Topics: Alcohol Drinking; Ampicillin; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; HMGB1 Protein; Male; Rats; Receptor for Advanced Glycation End Products; Receptors, N-Methyl-D-Aspartate; Sulbactam | 2020 |
A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone.
Topics: Ampicillin; Animals; Ceftriaxone; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Mice; Rabbits | 2020 |
Fluorothiazinon, a small-molecular inhibitor of T3SS, suppresses salmonella oral infection in mice.
Topics: Ampicillin; Anilides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Host-Pathogen Interactions; Macrophages, Peritoneal; Male; Mice, Inbred Strains; Rabbits; Salmonella Food Poisoning; Salmonella Infections; Salmonella typhimurium; Thiadiazines; Tissue Distribution; Type III Secretion Systems | 2021 |
Apigenin and Ampicillin as Combined Strategy to Treat Severe
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Apigenin; Binding Sites; Cell Line; Cell Survival; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythrocytes; Hemolysin Proteins; Host-Pathogen Interactions; Humans; Inflammation Mediators; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Streptococcal Infections; Streptococcus suis; Structure-Activity Relationship; Treatment Outcome | 2021 |
Beyond the uterine environment: a nonhuman primate model to investigate maternal-fetal and neonatal outcomes following chronic intrauterine infection.
Topics: Ampicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Behavior, Animal; Brain; Chronic Disease; Disease Models, Animal; Female; Humans; Infant, Newborn; Macaca mulatta; Pregnancy; Ureaplasma; Ureaplasma Infections; Uterine Diseases | 2017 |
Antibiotic-associated Manipulation of the Gut Microbiota and Phenotypic Restoration in NOD Mice.
Topics: Ampicillin; Animal Husbandry; Animals; Anti-Bacterial Agents; Decontamination; Diabetes Mellitus, Type 1; Disease Models, Animal; Environmental Monitoring; Feces; Gastrointestinal Microbiome; Genetic Predisposition to Disease; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Host-Pathogen Interactions; Intestines; Mice, Inbred NOD; Phenotype; Th1 Cells; Th17 Cells; Time Factors | 2017 |
Within-host spatiotemporal dynamics of systemic Salmonella infection during and after antimicrobial treatment.
Topics: Ampicillin; Animal Structures; Animals; Anti-Bacterial Agents; Bacterial Load; Blood; Ciprofloxacin; Disease Models, Animal; Female; Mice, Inbred C57BL; Salmonella; Salmonella Infections; Sepsis; Spatio-Temporal Analysis | 2017 |
Functionalization of β-lactam antibiotic on lysozyme capped gold nanoclusters retrogress MRSA and its persisters following awakening.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Gold; Injections, Intraperitoneal; Male; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Muramidase; Rats; Staphylococcal Infections; Treatment Outcome | 2018 |
β-lactams modulate astroglial glutamate transporters and attenuate dependence to CP 55,940, a CB1 receptor agonist, in rat model.
Topics: Amino Acid Transport System X-AG; Ampicillin; Animals; Astrocytes; beta-Lactams; Brain; Cannabinoid Receptor Agonists; Central Nervous System Agents; Cyclohexanols; Disease Models, Animal; Drug-Seeking Behavior; Gene Expression; Male; Rats; Receptor, Cannabinoid, CB1; Substance-Related Disorders; Sulbactam | 2019 |
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia.
Topics: Ampicillin; Analysis of Variance; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Chemokine CCL3; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Mice; Mice, Inbred C57BL; Pneumonia, Pneumococcal; Statistics, Nonparametric; Streptococcus pneumoniae; Survival Analysis; Time Factors | 2018 |
Effects of boric acid-linked ampicillin on the rat intra-abdominal sepsis model.
Topics: Abdomen; Ampicillin; Animals; Anti-Bacterial Agents; Boric Acids; Disease Models, Animal; Female; Interleukin-6; Rats, Wistar; Sepsis | 2019 |
Chinese yam (Dioscorea opposita Thunb.) alleviates antibiotic-associated diarrhea, modifies intestinal microbiota, and increases the level of short-chain fatty acids in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cecum; Diarrhea; Dioscorea; Disease Models, Animal; Fatty Acids, Volatile; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred BALB C; Plant Extracts | 2019 |
Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.
Topics: Ampicillin; Analysis of Variance; Animals; Anti-Bacterial Agents; Disease Models, Animal; Disease Outbreaks; Escherichia coli Infections; Female; Germany; Mice; Mice, Inbred C57BL; Rabbits; Shiga Toxin 2; Shiga-Toxigenic Escherichia coli; Virulence | 2013 |
Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Colon; Cytokines; Diarrhea; Disease Models, Animal; Enterocolitis; Female; Granuloma; Hyperplasia; Ileum; Immunologic Factors; Inflammatory Bowel Diseases; Interleukin-10; Intestinal Mucosa; Killer Cells, Natural; Leukocyte Count; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Neutrophils; Piroxicam; Weight Loss | 2014 |
Effect of intestinal function-recovering decoction on treatment of multiple organ dysfunction syndrome in rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Translocation; Disease Models, Animal; Drugs, Chinese Herbal; Endotoxins; Female; Intestinal Mucosa; Male; Malondialdehyde; Multiple Organ Failure; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2013 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
Antibiotics modulate intestinal immunity and prevent necrotizing enterocolitis in preterm neonatal piglets.
Topics: Amino Acids; Ampicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Antibiotic Prophylaxis; Disease Models, Animal; Enterocolitis, Necrotizing; Female; Gentamicins; Immunity, Mucosal; Intestinal Mucosa; Intestines; Metronidazole; Microbiota; Obstetric Labor, Premature; Pregnancy; Swine | 2014 |
Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice.
Topics: Adaptive Immunity; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Dexamethasone; Disease Models, Animal; Dogs; Female; Influenza A Virus, H1N1 Subtype; Kaplan-Meier Estimate; Lung; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred BALB C; Pneumonia, Pneumococcal | 2014 |
Immunomodulatory treatment with thalidomide in experimental leptospirosis in Golden Syrian hamsters (Mesocricetus auratus).
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Female; Immunosuppressive Agents; Kaplan-Meier Estimate; Leptospirosis; Mesocricetus; Thalidomide | 2014 |
An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics.
Topics: Ampicillin; Anaerobiosis; Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Mice, Inbred ICR; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Vancomycin | 2015 |
[99mTc]Annexin V-128 SPECT Monitoring of Splenic and Disseminated Listeriosis in Mice: a Model of Imaging Sepsis.
Topics: Ampicillin; Animals; Annexin A5; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Microbial; Female; Listeria monocytogenes; Listeriosis; Mice; Organotechnetium Compounds; Radiopharmaceuticals; Sepsis; Spleen; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2015 |
Combatting bacterial infections by killing persister cells with mitomycin C.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Ciprofloxacin; Cross-Linking Reagents; Cystic Fibrosis; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Escherichia coli K12; Humans; Mitomycin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Stimulation of apical sodium-dependent bile acid transporter expands the bile acid pool and generates bile acids with positive feedback properties.
Topics: Ampicillin; Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Cholic Acids; Deoxycholic Acid; Disease Models, Animal; Feedback, Physiological; Humans; Mice; Mice, Knockout; Organic Anion Transporters, Sodium-Dependent; Phenotype; Receptors, Cytoplasmic and Nuclear; Symporters | 2015 |
[Prophylaxis of purulent complications in mechanical ileus].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Biological Transport; Cephalosporins; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Gentamicins; Ileus; Peritonitis; Permeability; Rats; Rats, Wistar | 2015 |
Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model.
Topics: Ampicillin; Animals; CD8-Positive T-Lymphocytes; Cell Proliferation; Cisplatin; Disease Models, Animal; Humans; Inflammation; Lactobacillus; Lung Neoplasms; Mice; Microbiota; Neomycin; Neoplasm Proteins; Probiotics; Vancomycin | 2015 |
Use of aminoglycoside 3' adenyltransferase as a selection marker for Chlamydia trachomatis intron-mutagenesis and in vivo intron stability.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Proteins; Chlamydia Infections; Chlamydia trachomatis; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Female; Genetic Markers; Genomic Instability; Humans; Introns; Mice; Mice, Inbred BALB C; Mutagenesis, Insertional; Nucleotidyltransferases; Spectinomycin; Vagina | 2015 |
Enteral but not parenteral antibiotics enhance gut function and prevent necrotizing enterocolitis in formula-fed newborn preterm pigs.
Topics: Ampicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Biological Availability; Disease Models, Animal; Enterocolitis, Necrotizing; Female; Gastrointestinal Microbiome; Gentamicins; Gram-Positive Bacteria; Infant Formula; Infusions, Intra-Arterial; Intestines; Intubation, Gastrointestinal; Metronidazole; Pregnancy; Premature Birth; Swine; Treatment Outcome | 2016 |
In a Neonatal Piglet Model of Intestinal Failure, Administration of Antibiotics and Lack of Enteral Nutrition Have a Greater Impact on Intestinal Microflora Than Surgical Resection Alone.
Topics: Ampicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Models, Animal; DNA, Bacterial; Drug Combinations; Enteral Nutrition; Enterococcus; Gastrointestinal Microbiome; Intestines; Lactobacillus; Parenteral Nutrition; Sepsis; Sequence Analysis, DNA; Short Bowel Syndrome; Sulfadoxine; Swine; Trimethoprim | 2017 |
Multistrain models predict sequential multidrug treatment strategies to result in less antimicrobial resistance than combination treatment.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Load; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Injections, Intramuscular; Intestines; Microbial Sensitivity Tests; Swine; Tetracycline | 2016 |
Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Ampicillin; Anastomosis, Surgical; Animals; Anti-Bacterial Agents; Barrett Esophagus; Disease Models, Animal; DNA, Bacterial; DNA, Ribosomal; Esophageal Neoplasms; Esophagus; Gastroesophageal Reflux; Jejunum; Male; Metronidazole; Microbiota; Neomycin; Penicillin G; Polymorphism, Restriction Fragment Length; Random Allocation; Rats; Rats, Wistar; Streptomycin; Vancomycin | 2016 |
Modeling the growth dynamics of multiple Escherichia coli strains in the pig intestine following intramuscular ampicillin treatment.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Injections, Intramuscular; Intestines; Microbial Sensitivity Tests; Models, Theoretical; Swine; Time Factors | 2016 |
Evaluation of a model for studies on sequelae after acute otitis media in the Mongolian gerbil.
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Edema; Female; Gerbillinae; Microscopy; Otitis Media; Otoscopy; Pneumococcal Infections; Streptococcus pneumoniae; Tympanic Membrane; Tympanic Membrane Perforation; Wound Healing | 2009 |
Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Clindamycin; Disease Models, Animal; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Inflammation; Influenza A virus; Lung; Mice; Mice, Inbred BALB C; N-Acetylmuramoyl-L-alanine Amidase; Orthomyxoviridae Infections; Pneumonia, Pneumococcal; Protein Synthesis Inhibitors; Tumor Necrosis Factor-alpha | 2009 |
Multiple therapeutic effects of adjunctive baicalin therapy in experimental bacterial meningitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Blood Pressure; Brain Edema; Cerebrospinal Fluid Proteins; Disease Models, Animal; Diuretics, Osmotic; Drug Therapy, Combination; Escherichia coli Infections; Flavonoids; Interleukin-1; Intracranial Pressure; Lactic Acid; Leukocyte Count; Mannitol; Meningitis, Bacterial; Rabbits; Tumor Necrosis Factor-alpha; Water | 2010 |
Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
Topics: 16,16-Dimethylprostaglandin E2; Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Capsaicin; Cimetidine; Disease Models, Animal; Enterobacteriaceae; Famotidine; Histamine H2 Antagonists; Intestinal Mucosa; Intestine, Small; Male; Mucin-2; Nitric Oxide Synthase Type II; Omeprazole; Peptic Ulcer; Peroxidase; Phenylpropionates; Piperidines; Proton Pump Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sensory Receptor Cells | 2010 |
Superior effect of hypertonic saline over mannitol to attenuate cerebral edema in a rabbit bacterial meningitis model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Brain Edema; Chemotherapy, Adjuvant; Disease Models, Animal; Diuretics, Osmotic; Mannitol; Meningitis, Escherichia coli; Rabbits; Saline Solution, Hypertonic | 2011 |
Inactivation of MuxABC-OpmB transporter system in Pseudomonas aeruginosa leads to increased ampicillin and carbenicillin resistance and decreased virulence.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Brassica rapa; Carbenicillin; Disease Models, Animal; Drosophila melanogaster; Gene Deletion; Membrane Transport Proteins; Plant Diseases; Pseudomonas aeruginosa; Virulence; Virulence Factors | 2011 |
Design and synthesis of some new theophylline derivatives with bronchodilator and antibacterial activities.
Topics: Aminophylline; Ampicillin; Animals; Anti-Bacterial Agents; Asthma; Bronchial Spasm; Bronchodilator Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Male; Mice; Theophylline; Toxicity Tests, Acute | 2011 |
Effect of Lactobacillus acidophilus & epidermal growth factor on experimentally induced Clostridium difficile infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ampicillin; Animals; Cecum; Clostridioides difficile; Colon; Disease Models, Animal; Enterocolitis, Pseudomembranous; Epidermal Growth Factor; Ileum; Lactobacillus acidophilus; Lansoprazole; Mice; Mice, Inbred BALB C; Peroxidase; Probiotics | 2011 |
Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis.
Topics: Acute Kidney Injury; Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Immunohistochemistry; Inflammation; Kaplan-Meier Estimate; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Assessment; Sepsis; Statistics, Nonparametric; Sulbactam; Survival Rate; Time Factors | 2012 |
A.actinomycetemcomitans-induced periodontal disease promotes systemic and local responses in rat periodontium.
Topics: Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Alveolar Bone Loss; Ampicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; CD8-Positive T-Lymphocytes; Chemotaxis, Leukocyte; Disease Models, Animal; Epithelial Attachment; Kanamycin; Monocytes; Neutrophil Activation; Osteoclasts; Periodontal Attachment Loss; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2012 |
Design and synthesis of new 8-anilide theophylline derivatives as bronchodilators and antibacterial agents.
Topics: Aminophylline; Ampicillin; Anilides; Animals; Anti-Bacterial Agents; Asthma; Bronchial Spasm; Bronchodilator Agents; Disease Models, Animal; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Male; Mice; Structure-Activity Relationship; Theophylline | 2012 |
Effect of low-intensity focused ultrasound on the middle ear in a mouse model of acute otitis media.
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Ear, Middle; Haemophilus Infections; Haemophilus influenzae; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Otitis Media; Otitis Media with Effusion; Peptide Fragments; Severity of Illness Index; Sodium Chloride; Tumor Necrosis Factor-alpha; Ultrasonic Therapy | 2013 |
Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection.
Topics: Ampicillin; Analysis of Variance; Animals; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Eustachian Tube; Male; Otitis Media with Effusion; Penicillins; Rats; Streptococcal Infections; Streptococcus pneumoniae; Up-Regulation | 2002 |
Role of bacteria and inducible nitric oxide synthase activity in the systemic inflammatory microvascular response provoked by indomethacin in the rat.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Capillary Permeability; Dexamethasone; Disease Models, Animal; Indomethacin; Inflammation; Intestines; Male; Metronidazole; Microcirculation; Multiple Organ Failure; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organ Specificity; Polymyxin B; Rats; Rats, Wistar; Serum Albumin, Radio-Iodinated; Sulfones | 2003 |
In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Clarithromycin; Disease Models, Animal; Goblet Cells; Humans; In Vitro Techniques; Josamycin; Male; Mucus; Nasal Mucosa; Nose Neoplasms; Penicillins; Rats; Rats, Inbred F344; Respiratory Hypersensitivity; Secretory Rate | 2003 |
The effect of antibiotic therapy on intrauterine infection-induced preterm parturition in rabbits.
Topics: Ampicillin; Animals; Body Temperature; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; Injections, Intramuscular; Pregnancy; Pregnancy Complications, Infectious; Rabbits; Random Allocation; Sulbactam | 2003 |
Protective T cell response against intracellular pathogens in the absence of Toll-like receptor signaling via myeloid differentiation factor 88.
Topics: Adaptor Proteins, Signal Transducing; Ampicillin; Animals; Antigens, Differentiation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Immunity, Active; Listeria monocytogenes; Listeriosis; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Receptors, Cell Surface; Receptors, Immunologic; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptors | 2004 |
Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Antiviral Agents; Bacterial Adhesion; Cell Line; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Female; Influenza A virus; Mice; Mice, Inbred BALB C; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Treatment Outcome | 2004 |
Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aortic Valve; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Fluoroquinolones; Heart Valve Diseases; Moxifloxacin; Quinolines; Rabbits; Streptococcal Infections; Streptococcus oralis | 2005 |
Persistent joint swelling and Borrelia-specific antibodies in Borrelia garinii-infected mice after eradication of vegetative spirochetes with antibiotic treatment.
Topics: Achilles Tendon; Ampicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Borrelia burgdorferi Group; Ceftriaxone; Disease Models, Animal; Female; Histocytochemistry; Immunoglobulin G; Joint Diseases; Joints; Lyme Disease; Lymphocytes; Mice; Mice, Inbred C3H; Synovial Membrane | 2006 |
Do antibiotics contribute to postoperative ileus? Contractile responses of ileum smooth muscle in Guinea pigs to long-term parenteral ceftriaxone and ampicillin.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ceftriaxone; Disease Models, Animal; Follow-Up Studies; Guinea Pigs; Ileum; Ileus; Injections, Intramuscular; Male; Muscle Contraction; Muscle, Smooth; Postoperative Complications; Time Factors | 2006 |
Efficacy of vitamin A in experimentally induced acute otitis media.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Otitis Media; Pneumococcal Infections; Rats; Rats, Wistar; Treatment Outcome; Vitamin A; Vitamins | 2007 |
Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model.
Topics: Amnion; Amniotic Fluid; Ampicillin; Animals; Anti-Bacterial Agents; Cesarean Section; Chorioamnionitis; Chorion; Cytokines; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Female; Glucocorticoids; Immunologic Factors; Indomethacin; Macaca mulatta; Matrix Metalloproteinase 9; Obstetric Labor, Premature; Pregnancy | 2007 |
Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis.
Topics: Ampicillin; Animals; Aza Compounds; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Humans; Male; Meningitis, Listeria; Moxifloxacin; Quinolines; Rabbits | 2008 |
Response of the rat intestinal microcirculation to experimental endotoxemia is attenuated by ampicillin but not by its derivative KKP723.
Topics: Ampicillin; Animals; Disease Models, Animal; Endotoxemia; Intestinal Mucosa; Intestines; Lipopolysaccharides; Male; Microcirculation; Rats; Rats, Inbred Lew | 2008 |
Murine model for therapy of listeriosis in the compromised host. I. Effect of ampicillin.
Topics: Ampicillin; Animals; Dextran Sulfate; Dextrans; Disease Models, Animal; Listeriosis; Male; Mice; Mice, Nude; Spleen | 1981 |
Comparative activity of mecillinam and ampicillin singly and in combination in the urinary bladder model and experimental mouse model.
Topics: Amdinocillin; Ampicillin; Animals; beta-Lactamases; Disease Models, Animal; Drug Combinations; Enterobacteriaceae; Humans; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Urinary Bladder; Urinary Tract Infections | 1981 |
The antibacterial activity of combinations of mecillinam and ampicillin in vitro and in normal and granulopenic mice.
Topics: Amdinocillin; Ampicillin; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Granulocytes; Leukopenia; Male; Mice; Penicillanic Acid | 1983 |
Comparison of in vitro and in vivo ampicillin susceptibility of Escherichia coli pretreated with low concentrations of mecillinam and ampicillin.
Topics: Amdinocillin; Ampicillin; Animals; Colony-Forming Units Assay; Disease Models, Animal; Drug Synergism; Escherichia coli; Granulocytes; Leukopenia; Male; Mice; Microbial Sensitivity Tests; Penicillanic Acid | 1983 |
Treatment of ampicillin-resistant acute otitis media in the chinchilla.
Topics: Acute Disease; Ampicillin; Animals; Chinchilla; Disease Models, Animal; Haemophilus Infections; Haemophilus influenzae; Otitis Media; Penicillanic Acid; Penicillin Resistance; Sulbactam | 1983 |
Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
Topics: Ampicillin; Animals; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Disease Models, Animal; Gentamicins; Male; Meningitis; Moxalactam; Netilmicin; Rabbits; Species Specificity | 1980 |
Towards a rational approach to the treatment of peritonitis: an experimental study in rats.
Topics: Amikacin; Ampicillin; Animals; Cephradine; Disease Models, Animal; Injections, Intramuscular; Isotonic Solutions; Male; Metronidazole; Noxythiolin; Peritonitis; Povidone-Iodine; Rats; Rats, Inbred Strains; Rectum; Ringer's Lactate; Therapeutic Irrigation | 1984 |
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.
Topics: Ampicillin; Animals; Chloramphenicol; Disease Models, Animal; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Rabbits | 1983 |
[Experimental studies on the chemotherapeutic effect on retrograde Proteus pyelonephritis in rats (author's transl)].
Topics: Ampicillin; Animals; Disease Models, Animal; Female; Proteus Infections; Proteus mirabilis; Pyelonephritis; Rats; Rats, Inbred Strains | 1981 |
The effect of glucan--a host resistance activator--and ampicillin on experimental intraabdominal sepsis.
Topics: Abscess; Ampicillin; Animals; Disease Models, Animal; Drug Therapy, Combination; Glucans; Immunity, Innate; Male; Peritonitis; Rats; Rats, Inbred Strains | 1982 |
Treatment of experimental acute otitis media with ibuprofen and ampicillin.
Topics: Acute Disease; Ampicillin; Animals; Chinchilla; Disease Models, Animal; Drug Therapy, Combination; Eicosanoids; Exudates and Transudates; Ibuprofen; Otitis Media; Pneumococcal Infections | 1995 |
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Topics: Ampicillin; Animals; Aortic Valve; beta-Lactamases; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Rabbits; Sulbactam; Vancomycin | 1993 |
A rabbit model for ascending infection in pregnancy: intervention with indomethacin and delayed ampicillin-sulbactam therapy.
Topics: Ampicillin; Animals; Chorioamnionitis; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Female; Indomethacin; Pregnancy; Pregnancy Complications, Infectious; Premedication; Rabbits; Sulbactam; Time Factors; Treatment Outcome; Uterine Cervical Diseases | 1993 |
Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice.
Topics: Ampicillin; Animals; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Disease Models, Animal; Escherichia coli Infections; Fluorouracil; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillins; Pseudomonas Infections; Survival Analysis | 1996 |
Streptococcus pneumoniae in the nasal cavity of mice causes lower respiratory tract infection after airway obstruction.
Topics: Airway Obstruction; Ampicillin; Animals; Antibodies, Bacterial; Colony Count, Microbial; Disease Models, Animal; Female; Formaldehyde; Lung; Mice; Mice, Inbred CBA; Nasal Mucosa; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Trachea | 1996 |
The effect of timing of single-dose transplacental ampicillin-sulbactam therapy for prevention of neonatal group B streptococcal colonization and bacteremia in a rabbit model.
Topics: Ampicillin; Animals; Animals, Newborn; Bacteremia; Disease Models, Animal; Drug Therapy, Combination; Female; Oropharynx; Pregnancy; Rabbits; Streptococcal Infections; Streptococcus agalactiae; Sulbactam; Time Factors | 1996 |
Ascending group B streptococcal genital infection in the rabbit model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Genital Diseases, Female; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rabbits; Streptococcal Infections; Streptococcus agalactiae; Sulbactam | 1996 |
Distribution of systemically administered ampicillin, benzylpenicillin, and flucloxacillin in excisional wounds in diabetic and normal rats and effects of local topical vasodilator treatment.
Topics: Acetylcholine; Administration, Topical; Ampicillin; Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Disease Models, Animal; Floxacillin; Male; Nitroprusside; Penicillin G; Penicillins; Rats; Rats, Wistar; Tissue Distribution; Vasodilator Agents; Wound Healing; Wounds and Injuries | 1996 |
Survival rate of mice after transient colonization with Escherichia coli clones carrying variant Shiga-like toxin type II operons.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Toxins; Disease Models, Animal; Enterotoxins; Escherichia coli; Escherichia coli Infections; Feces; Male; Mice; Mice, Inbred BALB C; Operon; Penicillins; Plasmids; Polymerase Chain Reaction; Shiga Toxin 2; Streptomycin; Survival Rate; Virulence | 1996 |
Model of Streptococcus pneumoniae meningitis in adult rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Brain; Cefotaxime; Cerebrospinal Fluid; Disease Models, Animal; Gentamicins; Male; Meninges; Meningitis; Rats; Rats, Sprague-Dawley; Rodent Diseases; Rodentia; Streptococcus pneumoniae | 1996 |
Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Disease Models, Animal; Escherichia coli Infections; Male; Mice; Peritoneal Diseases; Piperacillin | 1996 |
Pharmacokinetics of ampicillin and sulfadimidine in pigs infected experimentally with Streptococcus suum.
Topics: Ampicillin; Animals; Anti-Infective Agents; Disease Models, Animal; Female; Half-Life; Injections, Intramuscular; Injections, Intravenous; Male; Penicillins; Streptococcal Infections; Sulfamethazine; Swine; Swine Diseases | 1997 |
[Characteristics of etiotropic therapy of plaque infection induced by atypical strains of F1- phenotype plaque microbe].
Topics: Aminoglycosides; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antigens, Bacterial; Aztreonam; Bacterial Proteins; Cephalosporins; Disease Models, Animal; Doxycycline; Fluoroquinolones; Mice; Monobactams; Penicillins; Phenotype; Plague; Rifampin | 1998 |
Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection.
Topics: Ampicillin; Animals; Bacterial Translocation; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterobacteriaceae; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Intestinal Mucosa; Intestines; Lactobacillus; Mesocricetus; Mice; Mice, Inbred BALB C; Penicillins; Probiotics; Xylitol | 1998 |
Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac.
Topics: Acoustic Stimulation; Ampicillin; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Auditory Threshold; Dexamethasone; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Loss, Sensorineural; Ketorolac; Meningitis, Pneumococcal; Penicillins; Rabbits; Tolmetin | 1999 |
Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit.
Topics: Ampicillin; Animals; Cell Wall; Disease Models, Animal; Female; Interleukin-1; Leukocytes; Meningitis, Pneumococcal; Penicillins; Polysaccharides; Rabbits; Streptococcus pneumoniae; Tumor Necrosis Factor-alpha | 1999 |
Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1999 |
Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Toxins; Brain Chemistry; Disease Models, Animal; Disease Progression; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Kanamycin; Mice; Mice, Inbred C57BL; Norfloxacin; Protein-Energy Malnutrition; Reference Values; Sensitivity and Specificity; Shiga Toxins; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
Topics: Aminoglycosides; Ampicillin; Animals; Anti-Bacterial Agents; Dibekacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rabbits; Treatment Outcome | 2000 |
Successful trovafloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.
Topics: Ampicillin; Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Aortic Valve; Disease Models, Animal; Endocarditis, Bacterial; Female; Fluoroquinolones; Heart Valve Diseases; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Rabbits; Streptococcal Infections; Streptococcus | 2000 |
Interleukin-1 receptor antagonist as an adjunct in the treatment of Haemophilus influenzae otitis media in the chinchilla.
Topics: Ampicillin; Animals; Chinchilla; Disease Models, Animal; Drug Therapy, Combination; Haemophilus Infections; Haemophilus influenzae; Injections, Intramuscular; Interleukin 1 Receptor Antagonist Protein; Otitis Media; Penicillins; Pilot Projects; Random Allocation; Receptors, Interleukin-1; Sialoglycoproteins | 2000 |
Effect of granulocyte-macrophage colony-stimulating factor on treatment of acute osteomyelitis. An experimental investigation in rats.
Topics: Acute Disease; Ampicillin; Animals; Biopsy, Needle; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Granulocyte-Macrophage Colony-Stimulating Factor; Injections, Intramuscular; Osteomyelitis; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Staphylococcus aureus; Sulbactam; Treatment Outcome | 2001 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
Virulence of Streptococcus mutans: an antibiotic-suppressed rat model for studies of pathogenesis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Carbenicillin; Cephalothin; Chloramphenicol; Dental Caries; Disease Models, Animal; Feces; Mouth; Rats; Streptococcus; Streptococcus mutans; Virulence | 1977 |
Cefamandole and ampicillin therapy in experimental Haemophilus influenzae meningitis.
Topics: Ampicillin; Animals; Blood; Cephalosporins; Cerebrospinal Fluid; Disease Models, Animal; Haemophilus influenzae; Injections, Intramuscular; Injections, Intravenous; Meningitis, Haemophilus; Rabbits | 1977 |
[On the activity of amoxicillin against experimental Treponema infection (author's transl)].
Topics: Amoxicillin; Ampicillin; Animals; Disease Models, Animal; Male; Penicillin Resistance; Rabbits; Syphilis; Treponema pallidum | 1977 |
Synergism of ampicillin and gentamicin against obstructive pyelonephritis due to Escherichia coli in rats.
Topics: Acute Disease; Ampicillin; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; In Vitro Techniques; Male; Pyelonephritis; Rats; Recurrence | 1979 |
Prevention of pyelonephritis due to Escherichia coli in rats with gentamicin stored in kidney tissue.
Topics: Ampicillin; Animals; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Gentamicins; Kidney; Male; Pyelonephritis; Rats; Recurrence | 1979 |
Efficacy of bacampicillin and ampicillin in experimental pyelonephritis in the rat.
Topics: Ampicillin; Animals; Bacteriuria; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Kidney; Pyelonephritis; Rats | 1979 |
Activity of oral amoxicillin, ampicillin, and oxytetracycline against infection with chlamydia trachomatis in mice.
Topics: Administration, Oral; Amoxicillin; Ampicillin; Animals; Chlamydia Infections; Chlamydia trachomatis; Disease Models, Animal; Mice; Oxytetracycline; Pneumonia | 1979 |
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antitoxins; Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Enterocolitis, Pseudomembranous; Humans; Mesocricetus | 1978 |
[Level of antibiotics in the serum and tissue in experimental peritonitis].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Lung; Peritonitis; Rats; Respiratory Distress Syndrome; Tobramycin | 1977 |
Ampicillin and an ester in experimental Hemophilus influenzae meningitis.
Topics: Ampicillin; Animals; Blood-Brain Barrier; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Haemophilus influenzae; Meningitis, Haemophilus; Penicillins; Rabbits | 1976 |
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalexin; Clindamycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Injections, Intramuscular; Injections, Intravenous; Male; Penicillin G; Penicillin G Benzathine; Penicillin G Procaine; Rabbits; Streptococcus; Streptomycin; Vancomycin | 1975 |
[The effect of pivampicillin and probenecid on experimental syphilis in rabbits].
Topics: Administration, Oral; Ampicillin; Animals; Disease Models, Animal; Drug Therapy, Combination; Humans; Male; Pivampicillin; Probenecid; Rabbits; Syphilis | 1975 |
Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Peptides; Rats; Teicoplanin; Vancomycin | 1992 |
Synergistic effect of romurtide with ampicillin against pneumococcal pneumonia in mice.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Ampicillin; Animals; Bronchoalveolar Lavage Fluid; Complement C3; Disease Models, Animal; Drug Synergism; Injections, Subcutaneous; Leukocyte Count; Lung; Mice; Pneumonia, Pneumococcal | 1992 |
Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice.
Topics: Ampicillin; Animals; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hydrocortisone; Immunocompromised Host; Injections, Subcutaneous; Listeriosis; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests | 1992 |
Experimental rabbit model of meningitis produced by Haemophilus influenzae serotype c.
Topics: Ampicillin; Animals; Disease Models, Animal; Haemophilus Infections; Haemophilus influenzae; Kinetics; Rabbits; Serotyping; Virulence | 1992 |
Low-inoculum model of surgical wound infection.
Topics: Abscess; Ampicillin; Animals; Cefazolin; Disease Models, Animal; Female; Guinea Pigs; Half-Life; Injections, Subcutaneous; Male; Microspheres; Regression Analysis; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1992 |
Evaluation of effects of novel urease inhibitor, N-(pivaloyl)glycinohydroxamic acid on the formation of an infection bladder stone using a newly designed urolithiasis model in rats.
Topics: Ampicillin; Animals; Disease Models, Animal; Drug Therapy, Combination; Female; Hydroxamic Acids; Rats; Rats, Inbred Strains; Urease; Urinary Bladder Calculi; Urinary Tract Infections | 1991 |
A rabbit model for bacterially induced preterm pregnancy loss: intervention studies with ampicillin-sulbactam.
Topics: Ampicillin; Animals; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Female; Fetal Death; Injections, Intramuscular; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Rabbits; Sulbactam; Time Factors | 1991 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
In search of missing links in otology. II. Development of an implantable middle ear drug delivery system: initial studies of sustained ampicillin release for the treatment of otitis media.
Topics: Administration, Topical; Ampicillin; Animals; Biodegradation, Environmental; Chinchilla; Delayed-Action Preparations; Disease Models, Animal; Drug Administration Routes; Ear, Middle; Lactates; Lactic Acid; Otitis Media; Polyesters; Polymers | 1991 |
Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis.
Topics: Ampicillin; Animals; Disease Models, Animal; Enterococcus faecalis; Female; Injections, Intramuscular; Mice; Mice, Inbred Strains; Peritonitis; Streptococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
[Morphofunctional changes in the lymph nodes and microcirculatory bed of small-intestinal mesentery of dogs in septic peritonitis after endolymphatic administration of ampicillin].
Topics: Acute Disease; Ampicillin; Animals; Disease Models, Animal; Dogs; Female; Injections, Intralymphatic; Intestine, Small; Lymph Nodes; Male; Mesentery; Microcirculation; Peritonitis | 1990 |
Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam.
Topics: Ampicillin; Animals; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Microbial Sensitivity Tests; Osteomyelitis; Rabbits; Sodium Morrhuate; Staphylococcal Infections; Sulbactam | 1990 |
Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Topics: Acyltransferases; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Disease Models, Animal; Endocarditis, Bacterial; Hexosyltransferases; Imipenem; Methicillin; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Nafcillin; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Ticarcillin | 1990 |
Invasion of the inner ear by Haemophilus influenzae type b in experimental meningitis.
Topics: Ampicillin; Animals; Animals, Newborn; Ceftriaxone; Cochlea; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Haemophilus influenzae; Labyrinth Diseases; Labyrinthitis; Meningitis, Haemophilus; Rats; Specific Pathogen-Free Organisms | 1989 |
Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess.
Topics: Abdominal Muscles; Abscess; Ampicillin; Animals; Clindamycin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Peritoneal Diseases; Rats; Rats, Inbred Strains; Streptococcal Infections | 1989 |
Potentiation by nonspecific immunostimulation of the efficacy of antibiotics in the treatment of experimental bacterial infections.
Topics: Adjuvants, Immunologic; Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Corynebacterium; Disease Models, Animal; Female; Glycopeptides; Klebsiella Infections; Mice; Sepsis; Streptococcal Infections; Teicoplanin; Trans-Activators | 1989 |
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam | 1989 |
LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Male; Microbial Sensitivity Tests; Peptides; Pyelonephritis; Random Allocation; Rats; Rats, Inbred Strains; Streptococcal Infections; Vancomycin | 1988 |
Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model.
Topics: Acute Disease; Ampicillin; Animals; Azithromycin; Chinchilla; Disease Models, Animal; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Otitis Media | 1988 |
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
Topics: Ampicillin; Animals; Disease Models, Animal; Endocarditis, Bacterial; Enterococcus faecalis; Infusions, Intravenous; Injections, Intramuscular; Male; Rats; Rats, Inbred Strains; Streptococcal Infections | 1987 |
Middle-ear effusions following acute otitis media in the chinchilla animal model.
Topics: Acute Disease; Ampicillin; Animals; Chinchilla; Disease Models, Animal; Ear, Middle; Haemophilus influenzae; Otitis Media | 1986 |
Murine model for therapy of listeriosis in the compromised host. IV. Cotrimoxazole.
Topics: Ampicillin; Animals; Anti-Infective Agents, Urinary; Disease Models, Animal; Drug Combinations; Female; Listeria monocytogenes; Listeriosis; Mice; Mice, Nude; Microbial Sensitivity Tests; Spleen; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Enhancement of ampicillin efficacy by peroral levodopa in rat pyelonephritis.
Topics: Administration, Oral; Ampicillin; Animals; Catechols; Cephalothin; Dihydroxyphenylalanine; Disease Models, Animal; Drug Synergism; Edetic Acid; Escherichia coli Infections; Nitrofurantoin; Phenylacetates; Pyelonephritis; Rats; Time Factors | 1972 |
Combinations of edetic acid and antibiotics in the treatment of rat burns infected with a resistant strain of Pseudomonas aeruginosa.
Topics: Ampicillin; Animals; Burns; Disease Models, Animal; Edetic Acid; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Tetracycline; Wound Infection | 1973 |
The experimental production of vitamin B12 deficiency in the baboon (Papio cynocephalus). A 2-year study.
Topics: Ampicillin; Animals; Azo Compounds; Biopsy; Blood Cell Count; Body Weight; Disease Models, Animal; FIGLU Test; Folic Acid; Glutarates; Growth; Haplorhini; Hematocrit; Hepatectomy; Histidine; Liver; Male; Malonates; Papio; Propionates; Sodium; Valine; Vitamin B 12; Vitamin B 12 Deficiency | 1974 |
Experimental pyelonephritis in dogs. Result of urinary infection and vesicoureteral reflux.
Topics: Ampicillin; Animals; Bacteria; Bacterial Infections; Blood Pressure; Chronic Disease; Disease Models, Animal; Dogs; Escherichia coli; Escherichia coli Infections; Female; Kidney; Kidney Function Tests; Male; Proteus; Proteus Infections; Pyelonephritis; Radiography; Urethra; Urinary Bladder; Urinary Tract Infections; Urine; Vesico-Ureteral Reflux | 1973 |
An in vivo pyelonephritis assay for screening therapeutic agents.
Topics: Ampicillin; Animals; Carbenicillin; Disease Models, Animal; Diuresis; Escherichia coli; Escherichia coli Infections; Female; Kidney; Mice; Proteus Infections; Proteus mirabilis; Pseudomonas; Pseudomonas Infections; Pyelonephritis; Serratia | 1974 |
[Serum resistance and "nephropathogenicity" of E. coli. IV. Changes of virulence in vitro and in vivo].
Topics: Ampicillin; Animals; Blood Bactericidal Activity; Chloramphenicol; Chronic Disease; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Nalidixic Acid; Penicillin Resistance; Pyelonephritis; Rats; Streptomycin; Sulfonamides; Tetracycline; Virulence | 1974 |
[Treatment of brucellosis associated with corynebacterium parvum infection in mice with antibiotics (tetracycline, ampicillin, trimethoprim-sulfamethoxazole)].
Topics: Ampicillin; Animals; Brucellosis; Cell Count; Complement Fixation Tests; Corynebacterium Infections; Disease Models, Animal; Drug Combinations; Drug Interactions; Evaluation Studies as Topic; Female; Hemagglutination Tests; Injections, Intraperitoneal; Mice; Organ Size; Propionibacterium acnes; Pyrimidines; Spleen; Sulfamethoxazole; Tetracycline; Trimethoprim | 1972 |
Rat pyelonephritis model suitable for primary or secondary screening.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Escherichia coli Infections; Female; Gentamicins; Male; Nalidixic Acid; Nitrofurantoin; Proteus Infections; Pyelonephritis; Rats; Sulfamethoxazole; Sulfisoxazole | 1969 |
[Combined experimental use of polysynthetic penicillins].
Topics: Ampicillin; Animals; Blood; Depression, Chemical; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Kidney; Liver; Lung; Mice; Myocardium; Oxacillin; Penicillin Resistance; Penicillinase; Spleen; Staphylococcal Infections; Staphylococcus | 1970 |
The first phase of pseudomonadal pneumonia influenced by the administration of ampicillin + EDTA in vivo.
Topics: Ampicillin; Animals; Disease Models, Animal; Drug Synergism; Edetic Acid; Leukocytosis; Phagocytosis; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Alveoli; Rabbits | 1970 |
Pyelonephritis. XII. Comparison of penicillin, ampicillin, and streptomycin in enterococcal infection in rats.
Topics: Ampicillin; Animals; Bacteriological Techniques; Disease Models, Animal; Enterococcus faecalis; Injections, Intramuscular; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Pyelonephritis; Rats; Streptococcal Infections; Streptomycin | 1971 |
Corticosteroids and antibiotics for the treatment of fulminant hydrocarbon aspiration.
Topics: Ampicillin; Animals; Blood Cell Count; Carbon Dioxide; Dexamethasone; Disease Models, Animal; Dogs; Electrolytes; Hydrogen-Ion Concentration; Injections; Kerosene; Lung; Oxygen; Petroleum; Pneumonia, Aspiration; Poisoning; Pulse; Radiography; Respiration | 1972 |
[Effectiveness of polysynthetic penicillins in experimental anaerobic (gaseous) infection].
Topics: Ampicillin; Animals; Clostridium Infections; Disease Models, Animal; Drug Synergism; In Vitro Techniques; Injections, Intramuscular; Injections, Intravenous; Methicillin; Methods; Mice; Oxacillin; Penicillin Resistance; Penicillins | 1971 |
Production and therapy of Proteus mirabilis pyelonephritis in mice undergoing chronic diuresis.
Topics: Ampicillin; Animals; Disease Models, Animal; Diuresis; Mice; Proteus Infections; Pyelonephritis; Rats; Urinary Bladder Calculi | 1969 |
Chemotherapy of mice experimentally infected with Shigella flexneri.
Topics: Administration, Oral; Ampicillin; Animals; Antibodies; Colistin; Disease Models, Animal; Dysentery, Bacillary; Feces; Hemagglutination Tests; Intestines; Kanamycin; Lymph Nodes; Male; Mesentery; Mice; Neomycin; Oxytetracycline; Shigella | 1970 |